# FDA Inspection 1080931 - Gustavo Daniel Lopardo, M.D. - February 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/gustavo-daniel-lopardo-md/13328d4f-3d45-40d9-908e-6dafdc06aca6
Source feed: FDA_Inspections

> FDA Inspection 1080931 for Gustavo Daniel Lopardo, M.D. on February 20, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1080931
- Company Name: Gustavo Daniel Lopardo, M.D.
- Inspection Date: 2019-02-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/gustavo-daniel-lopardo-md/5c13ed83-b2ad-4883-8daa-7344ad443e60

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c